A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab

Clinical trial NCT02013154 · COMPLETED

Trial details

NCT number: NCT02013154
Sponsor: Leap Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Neoplasms Adenocarcinoma of the Gastroesophageal Junction Gastroesophageal Cancer Squamous Cell Carcinoma Gastric Adenocarcinoma

Start date: 2014-05-05
Primary completion: 2019-07-19
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.